3-Hydroxypyrazine-2-Carboxamide CAS 55321-99-8 Ịdị Ọcha>98.0% (HPLC) Favipiravir Intermediate COVID-19

Nkọwa dị mkpirikpi:

Aha ọgwụ: 3-Hydroxypyrazine-2-Carboxamide

Nọmba: 55321-99-8

Ọdịdị: Ìhè Yellow ruo Brown ntụ ntụ

Dị ọcha:> 98.0% (HPLC)

Ndị etiti nke Favipiravir (CAS: 259793-96-9) na ọgwụgwọ nke nje nje influenza na COVID-19

Ogo dị elu, mmepụta azụmahịa

Inquiry: alvin@ruifuchem.com

Zitere anyị email

Nkọwa ngwaahịa

Ngwaahịa ndị emetụtara

Mkpado ngwaahịa

Nkọwa:

Nbunye azụmaahịa Favipiravir na ihe ndị metụtara ya:
Favipiravir CAS 259793-96-9
2-Aminopropanediamide CAS 62009-47-6
Diethyl Aminomalonate Hydrochloride CAS 13433-00-6
3,6-Dichloropyrazine-2-Carbonitrile CAS 356783-16-9
3,6-Difluoropyrazine-2-Carbonitrile CAS 356783-28-3
6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile CAS 356783-31-8
6-Bromo-3-Hydroxypyrazine-2-Carboxamide CAS 259793-88-9
3-Hydroxypyrazine-2-Carboxamide CAS 55321-99-8

Njirimara kemịkalụ:

Aha Chemical	3-Hydroxypyrazine-2-Carboxamide
Ụdị okwu	T-1105;3-Hydroxy-2-Pyrazinecarboxamide;Favipiravir Desfluoro adịghị ọcha;3-Oxo-3,4-dihydropyrazine-2-carboxamide
Nọmba CAS	55321-99-8
Nọmba CAT	RF-PI295
Ọnọdụ Ahịa	N'ọkwa, Mpụta Ihe ruru Kilogram
Usoro ihe omimi	C5H5N3O2
Ibu molekụla	139.11
Ụdị	Ruifu Chemical

Nkọwapụta:

Ihe	Nkọwapụta
Ọdịdị	Agba odo na ntụ ntụ ntụ ntụ
njirimara	IR, HPLC
Ọnwụ na ihicha	<1.00%
Otu adịghị ọcha	<0.50%
Ọla dị arọ	≤20ppm
Ịdị ọcha	> 98.0% (HPLC)
Nlele ọkọlọtọ	Standardkpụrụ ụlọ ọrụ
Ojiji	Ọkara nke Favipiravir (CAS 259793-96-9)

Ngwungwu & Nchekwa:

ngwugwu: Kalama, Aluminom foil bag, 25kg / Drum, ma ọ bụ dị ka ndị ahịa chọrọ

Ọnọdụ Nchekwa:Na-echekwa n'ime akpa ndị a kpuchiri ekpuchi na ebe dị jụụ na nke kpọrọ nkụ;Chebe site na ìhè, mmiri mmiri

Uru:

Ajụjụ:

Ngwa:

3-Hydroxypyrazine-2-Carboxamide (CAS 55321-99-8) bụ etiti ma ọ bụ adịghị ọcha nke Favipiravir Intermediate (CAS 259793-96-9).Favipiravir bụ ọgwụ mgbochi nje na-agbasa mbara ọhụrụ.Enwere ike iji Favipiravir mee ihe maka ọgwụgwọ antiviral nke influenza A na B. Nnyocha egosiwo na na mgbakwunye na nje influenza, ọgwụ ahụ na-egosipụtakwa ọrụ antiviral dị mma megide nje virus dị iche iche RNA, dị ka nje Ebola, nje arena, Bunia virus, na rabies. nje.N'oge ntiwapụ nke Ọrịa Coronavirus ọhụrụ 2019 (COVID-19), enwere ike iji Favipiravir na ọgwụgwọ ndị ọrịa nwere COVID-19 nke WHO kwadoro.